Want to see AU:DEL full AI Analyst Report?
Top Page
Delorean Corporation Ltd
(Sydney:DEL)
Select Model
Select Model
Rating:46Neutral
Price Target:
AU$0.10
â–¼(-11.82% Downside)
Action:Reiterated
Date:07/04/26
The score is primarily weighed down by weak financial performance—sharp revenue decline, sustained losses, high leverage, and negative operating/free cash flow. Technicals provide partial offset with improving near-term trend and mildly positive momentum, but valuation is constrained by ongoing losses (negative P/E) and no dividend yield data.
Positive Factors
Vertical integration: development, engineering and operations
Delorean’s ownership and in‑house development, engineering and operations capabilities create a durable operational advantage. By internalising design, construction and O&M, the company can capture more project value, control commissioning and uptime, and reduce reliance on third parties—supporting steadier long‑term cash flows and faster project delivery if execution holds.
Negative Factors
Sharp revenue decline and negative margins
A near 41% revenue contraction combined with negative gross, EBIT and net margins signals structural weakness in demand, pricing or cost control. Persistent top‑line shrinkage and deeply negative margins erode scale economies, reduce reinvestment capacity, and make restoring profitability and sustainable cash generation materially harder over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Vertical integration: development, engineering and operations
Delorean’s ownership and in‑house development, engineering and operations capabilities create a durable operational advantage. By internalising design, construction and O&M, the company can capture more project value, control commissioning and uptime, and reduce reliance on third parties—supporting steadier long‑term cash flows and faster project delivery if execution holds.
Read all positive factors
Delorean Corporation Ltd (DEL) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$25.30M
Dividend YieldN/A
Average Volume (3M)184.85K
Price to Earnings (P/E)―
Beta (1Y)0.12
Revenue Growth-58.56%
EPS Growth-313.17%
CountryAU
Employees28
SectorUtilities
Sector Strength65
IndustryRenewable Utilities
Share Statistics
EPS (TTM)-0.04
Shares Outstanding253,011,550
10 Day Avg. Volume162,684
30 Day Avg. Volume184,848
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)4.60
Price to Sales (P/S)1.82
P/FCF Ratio-1.68
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Delorean Corporation Ltd Business Overview & Revenue Model
Company Description
Delorean Corporation Limited is an Australian enterprise deeply involved in the renewable energy and waste management industries across both Australia and New Zealand. Its comprehensive business model is segmented into Infrastructure, Engineering,...
How the Company Makes Money
Delorean makes money primarily by developing, owning, operating and monetising bioenergy projects. Key revenue streams typically include: (1) Sale of energy produced from biogas projects (e.g., electricity generated from captured biogas) under off...
Delorean Corporation Ltd Financial Statement Overview
Summary
Income Statement
25
Negative
Balance Sheet
30
Negative
Cash Flow
35
Negative
| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 14.23M | 19.83M | 27.88M | 19.25M | 39.33M | 27.88M |
| Gross Profit | -5.73M | -2.99M | 7.83M | -7.18M | -6.77M | -342.89K |
| EBITDA | -7.89M | -6.13M | 5.04M | -9.06M | -11.87M | -4.08M |
| Net Income | -8.99M | -6.55M | 4.77M | -10.02M | -10.89M | -3.21M |
Balance Sheet | ||||||
| Total Assets | 50.62M | 48.30M | 28.05M | 17.92M | 24.10M | 28.77M |
| Cash, Cash Equivalents and Short-Term Investments | 4.85M | 10.66M | 8.84M | 1.00M | 3.12M | 13.07M |
| Total Debt | 38.45M | 31.31M | 9.07M | 7.62M | 2.63M | 2.78M |
| Total Liabilities | 46.75M | 40.45M | 19.28M | 15.75M | 12.21M | 12.50M |
| Stockholders Equity | 3.88M | 7.85M | 8.77M | 2.17M | 11.88M | 16.27M |
Cash Flow | ||||||
| Free Cash Flow | -26.62M | -21.50M | 6.89M | -6.80M | -15.21M | -2.59M |
| Operating Cash Flow | -3.24M | -5.66M | 7.24M | -5.36M | -11.77M | 156.59K |
| Investing Cash Flow | -21.51M | -15.08M | -3.92M | -1.44M | -3.44M | -4.49M |
| Financing Cash Flow | 16.22M | 23.33M | 915.22K | 4.68M | 5.26M | 14.49M |
Delorean Corporation Ltd Technical Analysis
Positive
0.11
Price Trends
0.09
Positive
0.10
Positive
0.11
Negative
Market Momentum
<0.01
Negative
66.25
Neutral
70.59
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:DEL, the sentiment is Positive. The current price of 0.11 is above the 20-day moving average (MA) of 0.09, above the 50-day MA of 0.09, and below the 200-day MA of 0.11, indicating a neutral trend. The MACD of <0.01 indicates Negative momentum. The RSI at 66.25 is Neutral, neither overbought nor oversold. The STOCH value of 70.59 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AU:DEL.
Delorean Corporation Ltd Peers Comparison
UnderperformOutperform
Sector (66)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
66 Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% | |
60 Neutral | AU$19.64M | 27.91 | 6.92% | ― | -8.32% | -67.69% | |
55 Neutral | AU$95.09M | -33.72 | -13.64% | ― | 16.99% | ― | |
51 Neutral | AU$44.00M | 2.88 | 105.12% | ― | ― | ― | |
46 Neutral | AU$25.30M | -2.45 | -153.29% | ― | -58.56% | -313.17% | |
| ― | AU$21.20M | -0.10 | -31.05% | ― | ― | ― | |
47 Neutral | AU$55.01M | -4.56 | -108.64% | ― | ― | -63.48% |
* Utilities Sector Average
AU:DEL
Delorean Corporation Ltd
0.10
-0.07
-41.18%
AU:CCE
Carnegie Clean Energy Ltd
0.23
0.18
342.31%
AU:JNS
ReNu Energy Limited
0.15
-0.03
-17.14%
AU:KPO
Kalina Power Limited
0.02
<0.01
66.67%
AU:14D
1414 Degrees Ltd.
0.08
0.06
331.58%
AU:VPR
Volt Power Group Ltd
0.12
-0.03
-20.00%
Delorean Corporation Ltd Corporate Events
Delorean Wins Extra $1.66m ARENA Funding for SA1 Bioenergy Plant
Jun 21, 2026
Delorean Corporation has secured an additional $1.66 million in grant funding from the Australian Renewable Energy Agency, lifting total ARENA support for its SA1 Salisbury bioenergy facility in South Australia to $7.74 million. The increased fund...
Delorean Director Increases Indirect Shareholding via Share Purchase Plan
May 29, 2026
Delorean Corporation has disclosed a change in director Steve Gostlow’s indirect interest in the company’s shares, following his participation in a share purchase plan. Through director-related entity Brykan Investments Pty Ltd, Gostlo...
Delorean Director Increases Indirect Shareholding via Share Purchase Plan
May 29, 2026
Delorean Corporation Limited has disclosed a change in director Joseph Oliver’s indirect interest, with his holding via The Geobay Family A/C increasing through participation in a share purchase plan. His beneficial ownership rose from 47,20...
Delorean Director Increases Stake via Share Purchase Plan
May 29, 2026
Delorean Corporation has disclosed a change in director Hamish Jolly’s relevant interests following his participation in the company’s share purchase plan. Through his indirect holdings via family-related entities, Jolly acquired 111,1...
Delorean Seeks ASX Quotation for 8.3 Million New Shares
May 29, 2026
Delorean Corporation has lodged an application with the ASX for the quotation of 8,333,405 ordinary fully paid shares, with an issue date of 29 May 2026. The move increases the number of DEL shares available for trading, potentially enhancing liqu...
Delorean raises $750,000 through completed share purchase plan
May 27, 2026
Delorean Corporation has closed its share purchase plan, which was offered to existing shareholders at $0.09 per share, matching the price of its recent strategic placement to LMS Energy. The offer, which allowed investors to subscribe for up to $...
Delorean stresses speculative risk and limits of investor presentation
May 13, 2026
Delorean Corporation Ltd has issued an investor update outlining the strictly informational nature of its latest corporate presentation, emphasising that it is not a prospectus, offer document or recommendation to buy, sell or hold its securities....
Delorean Director Michael Philip Steps Down with No Shareholdings Declared
May 10, 2026
Delorean Corporation Ltd has notified the ASX that director Michael Philip ceased to be a director on 11 May 2026, in line with listing rule disclosure requirements. The company reports that Philip holds no relevant interests in the firm’s s...
Delorean appoints new director with no current shareholding
May 10, 2026
Delorean Corporation Ltd has appointed Jared Thomas as a director effective 11 May 2026, according to a disclosure lodged with the ASX. The filing notes that Thomas currently holds no relevant interests in the company’s securities and has no...
Delorean adds Tanarra investment head to board as director retires
May 10, 2026
Delorean Corporation Ltd has appointed banking and investment specialist Jared Thomas as a Non-Executive Non-Independent Director, effective 11 May 2026, following the retirement of Non-Executive Director Michael Phillip on the same date. Thomas, ...
Delorean opens bioenergy project and management to investors with site tour and WA event
May 6, 2026
Delorean Corporation has announced two investor-focused events aimed at showcasing its build-own-operate bioenergy strategy and growing asset portfolio. The initiatives are designed to deepen engagement with shareholders and potential investors by...
Delorean sets May investor webinar to outline strategy and share plan
May 5, 2026
Delorean Corporation Limited, a leading Australian bioenergy specialist in renewable energy and waste management, operates an integrated model spanning engineering, infrastructure and energy retail to deliver bioenergy projects from conception to ...
Delorean launches shareholder offer to fund bioenergy growth push
May 4, 2026
Delorean Corporation has opened a share purchase plan for eligible shareholders, following a $2.2 million strategic placement to biogas specialist LMS Energy at $0.09 per share. The offer allows existing investors to acquire shares on the same ter...
Delorean launches compliant share purchase plan for eligible investors
May 3, 2026
Delorean Corporation Ltd has announced a share purchase plan offering eligible shareholders the opportunity to acquire up to $30,000 of new ordinary shares. The offer will be made without a full prospectus under ASIC Corporations Instrument 2019/5...
Delorean Raises Capital With 24.4 Million-Share Placement
Apr 30, 2026
Delorean Corporation has issued 24.4 million fully paid ordinary shares at $0.09 each via a placement to investors, expanding its capital base without providing a traditional disclosure document. The company states it is fully compliant with its f...
Delorean Options Lapse, Trimming Potential Future Dilution
Apr 30, 2026
Delorean Corporation has reported the cessation of 2,500,000 DELAH options, which were scheduled to expire on 30 November 2028 with an exercise price of $0.25. The options lapsed unexercised on 1 May 2026, resulting in a reduction of potential dil...
Delorean Options Lapse, Simplifying Capital Structure
Apr 30, 2026
Delorean Corporation Ltd has announced the cessation of 2,500,000 DELAG options, which were scheduled to expire on 30 November 2028 with an exercise price of $0.19. The options lapsed on 1 May 2026 without being exercised or converted, resulting i...
Delorean launches securities purchase plan to issue up to 73.4m shares
Apr 30, 2026
Delorean Corporation Limited has announced a securities purchase plan for its shareholders, offering up to 73,403,446 new ordinary fully paid shares. The offer is based on a record date of 29 April 2026 and is scheduled to close on 25 May 2026, wi...
Delorean secures $2.2m strategic biogas partner and launches $2.2m SPP
Apr 30, 2026
Delorean Corporation has secured a $2.2 million strategic investment from LMS Energy through a placement of 24.4 million shares at $0.09, giving LMS a 9.97% stake and bringing in a sector specialist that already operates more than 70 biogas projec...
Delorean advances Australian bioenergy pipeline with key project milestones and funding
Apr 30, 2026
Delorean reported a cash balance of $7.2 million at 31 March 2026 and customer receipts of $0.8 million for the quarter, highlighting continued investment in its bioenergy portfolio. The company is benefiting from strong policy momentum for renewa...
Delorean Seeks Two-Day Trading Halt Ahead of Capital Raising
Apr 29, 2026
Delorean Corporation has requested an immediate two-day trading halt on its ordinary shares on the ASX, effective from the market open on Wednesday, 29 April 2026. The halt is scheduled to last until either the company releases a further announcem...
Delorean Reaches Final Investment Decision on $62m NSW Bioenergy Plant
Apr 7, 2026
Delorean Corporation has approved a $62.1 million final investment decision for its 100%-owned NSW1 Horsley Park bioenergy facility in New South Wales, subject to securing $31.6 million in additional funding. The plant, co-located on Brickworks...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.